Atrial natriuretic factor reduces cell coupling in the failing heart, an effect mediated by cyclic GMP

J Cardiovasc Pharmacol. 1998 Jul;32(1):75-9. doi: 10.1097/00005344-199807000-00012.

Abstract

The influence of the atrial natriuretic factor (ANF) on heart-cell communication was investigated in cell pairs isolated from the ventricle of cardiomyopathic hamsters (BIO TO-2; 11 months old), and the results were compared with controls (F1B) of same age. The results indicated that ANF (10(-8) M) added to the bath caused a decline in junctional conductance (gj) of 48 +/- 2% (n = 15) within 90 s. The effect of ANF was suppressed by HS-142-1, a specific antagonist of guanylyl cyclase ANF receptor. Moreover, the decline in gj elicited by ANF was related to the synthesis of cyclic guanosine monophosphate (cGMP). Indeed, dibutyryl-cGMP (10(-4) M) decreased gj by 80 +/- 3.5% (n = 15) within 90 s, and zaprinast, a selective inhibitor of cGMP phosphodiesterase, enhanced the effect of ANF on gj. The possible relationship between ischemia, ANF release, and impairment of cell coupling is discussed.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 3',5'-Cyclic-AMP Phosphodiesterases / antagonists & inhibitors
  • Animals
  • Atrial Natriuretic Factor / pharmacology*
  • Bucladesine / pharmacology
  • Cardiomyopathies / genetics
  • Cardiomyopathies / pathology
  • Cell Communication / drug effects*
  • Cricetinae
  • Cyclic GMP / physiology*
  • Electrophysiology
  • Gap Junctions / drug effects
  • Heart Failure / pathology*
  • Heart Failure / physiopathology
  • Heart Ventricles / pathology
  • Male
  • Mesocricetus
  • Phosphodiesterase Inhibitors / pharmacology
  • Purinones / pharmacology
  • Receptors, Atrial Natriuretic Factor / antagonists & inhibitors

Substances

  • Phosphodiesterase Inhibitors
  • Purinones
  • Bucladesine
  • Atrial Natriuretic Factor
  • 3',5'-Cyclic-AMP Phosphodiesterases
  • Receptors, Atrial Natriuretic Factor
  • zaprinast
  • Cyclic GMP